Our study provides new insights into the underlying mechanisms of reduced CTLA4 expression observed in melanoma patients, demonstrating that post-transcriptional silencing of CTLA4 by miR-155 in Treg cells may play a critical role. This evidence concerns the gene CTLA4 and melanoma.